# Tim Friede

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tim-friede/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,785 |
| Field | Statistical Methods in Clinical Trials |
| h-index | 68 |
| i10-index | 274 |
| Last Known Institution | FIND |
| OpenAlex ID | https://openalex.org/A5057325416 |
| ORCID iD | https://orcid.org/0000-0001-5347-7441 |
| Works | 630 |

## Researcher papers

- [2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death](https://scholariq.org/papers/2022-esc-guidelines-for-the-management-of-patients-with-ventricular-arrhythmias/)
- [Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial](https://scholariq.org/papers/ferric-carboxymaltose-for-iron-deficiency-at-discharge-after-acute-heart-failure/)
- [Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis](https://scholariq.org/papers/randomized-controlled-trial-of-cannabis-based-medicine-in-central-pain-in/)
- [Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12](https://scholariq.org/papers/randomized-phase-ii-trial-of-chemoradiotherapy-plus-induction-or-consolidation/)
- [Warwick-Edinburgh Mental Well-being Scale (WEMWBS): Validated for teenage school students in England and Scotland. A mixed methods assessment](https://scholariq.org/papers/warwick-edinburgh-mental-well-being-scale-wemwbs-validated-for-teenage-school/)
- [Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy](https://scholariq.org/papers/early-angiotensin-converting-enzyme-inhibition-in-alport-syndrome-delays-renal/)
- [Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer](https://scholariq.org/papers/chemoradiotherapy-plus-induction-or-consolidation-chemotherapy-as-total/)
- [Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project)](https://scholariq.org/papers/multicomponent-intervention-to-prevent-mobility-disability-in-frail-older-adults/)
- [Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial](https://scholariq.org/papers/patiromer-for-the-management-of-hyperkalemia-in-heart-failure-with-reduced/)
- [A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome](https://scholariq.org/papers/a-multicenter-randomized-placebo-controlled-double-blind-phase-3-trial-with-open/)

## Researcher topics

- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Optimal Experimental Design Methods](https://scholariq.org/topics/optimal-experimental-design-methods/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Meta-analysis and systematic reviews](https://scholariq.org/topics/meta-analysis-and-systematic-reviews/)

## Researcher university

- [FIND](https://scholariq.org/institutions/find/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.